GE HealthCare Technologies (GEHC) EBT Margin (2022 - 2026)
GE HealthCare Technologies (GEHC) posted EBT Margin of 9.84% for Q1 2026, down 31.69% on a QoQ basis from 14.41% in Q4 2025, and down 464.0% year-over-year from 2.7% in Q1 2025.
GE HealthCare Technologies (GEHC) EBT Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' EBT Margin history runs 5 years deep, the most recent figure standing at 9.84% for Q1 2026.
- Quarterly EBT Margin fell 464.0% year-over-year to 9.84% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.31% (down 164.0% YoY) and the FY2025 annual result came in at 13.42%, up 30.0% from the prior year.
- EBT Margin was 9.84% for Q1 2026 at GE HealthCare Technologies, down from 14.41% in the prior quarter.
- Across five years, EBT Margin topped out at 15.68% in Q4 2024 and bottomed at 9.84% in Q1 2026.
- A 5-year average of 12.86% and a median of 12.5% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin surged 398 bps — and 2026, when it plunged 464 bps.
- GE HealthCare Technologies' EBT Margin stood at 14.54% in 2022, then slipped by 20 bps to 11.7% in 2023, then jumped by 34 bps to 15.68% in 2024, then declined by 8 bps to 14.41% in 2025, then slumped by 32 bps to 9.84% in 2026.
- Business Quant data shows GEHC's EBT Margin at 9.84% in Q1 2026, 14.41% in Q4 2025, and 12.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.84% |
| Dec 31, 2025 | 14.41% |
| Sep 30, 2025 | 12.50% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | 14.49% |
| Dec 31, 2024 | 15.68% |
| Sep 30, 2024 | 13.53% |
| Jun 30, 2024 | 11.94% |
| Mar 31, 2024 | 11.01% |
| Dec 31, 2023 | 11.70% |
| Sep 30, 2023 | 13.19% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | 11.60% |
| Dec 31, 2022 | 14.54% |
| Sep 30, 2022 | 13.59% |
| Jun 30, 2022 | 14.25% |
| Mar 31, 2022 | 12.27% |